About Us

M.S., State University of New York at Stony Brook, former Head of Bioanalytical Operations at Henlius.

8 years of bioanalytical GLP experience, worked in Frontage, Johnson & Johnson Bioanalytical Department, participated in clinical bioanalysis of Daratumumab, Ustekinumab, etc., and went through several FDA and EMA inspection. She is familiar with bioanalytical regulations in China, USA and EU, and has participated in the construction of several bioanalytical labs.

Ph.D., Sichuan University

With nearly 20 years of deep expertise in operations, strategy, and BD within pharmaceutical companies and drug R&D.Previously, he served as Chief Engineer, Vice President, General Manager at several biopharmaceutical companies, as well as Chairman and General Manager of CRO and CDMO. He possesses experience in corporate management, strategy, and commercial operations, demonstrating exceptional leadership and strategic insight.

Former Associate Director of Accounting at Henlius, Fosun.

With twenty years of financial management experience, Ms. previously served as Associate Director of Accounting at Fosun Henlius, oversight of the General Ledger and Financial Reporting function for the China entity, Europe, and Hong Kong. Ms. Zhou also held a key financial management position at Lonza Fosun, Wuxi AppTec and WuXi STA.

M.S., Shanghai Ocean University

She served as QA Auditor and Supervisor at WuXi AppTec, Henlius, and Zai Lab (Shanghai), respectively. With nearly 8 years of experience in bioanalytical industry QA systems, central lab operations, and study auditing, she has audited over 300 large and small molecule bioanalytical projects. As a key contributor, she participated in establishing the quality systems framework at Henlius and Zai Lab, and completed validation of the TrackWise Quality Management System. She holds GCP Certification, CSQA GLP Certification, ISO 15189 Certification, and Laboratory Quality Manager Certification.

M.S., Nanjing Agricultural University

With 8 years of GLP bioanalysis experience and previous roles at Henlius and WuXi AppTec, she has been responsible for multiple bioanalysis projects. She has led or participated in over 40 macromolecular drug projects, covering antibody drugs, ADCs, fusion proteins, and CGT. She has also guided teams through preclinical and clinical bioanalysis, supporting approvals from the NMPA, FDA, and EMA.

Ph.D., Soochow University

With nearly 5 years of experience in cell therapy drug analysis, he previously worked at Persongen and Cyagen Biosciences, serving as a Cell Therapy Researcher and Senior Cell Therapy Scientist respectively. He has participated in a total of more than 30 cell therapy drug projects such as CAR-T/NK/TCR-T. He is proficient in method development and sample analysis related to flow cytometry and qPCR, and provides full-process support from preclinical to clinical stages. He has an in-depth understanding of cell therapy mechanisms, is good at solving personalized testing challenges, and ensures data output at key nodes.